Nationwide recall issued for common hypertension drug due to dissolution defect

TL;DR
More than 11,000 bottles of chlorthalidone tablets (25 mg) used to treat high blood pressure have been recalled nationwide after a manufacturing issue caused dissolution specifications to fail. Inventia Healthcare Limited initiated the voluntary recall on June 5, with 100-count bottles (Lot RISA24001) and 1,000-count bottles (Lot RISB24002) distributed in the U.S. by Rising Pharma Holdings Inc. The FDA has not yet assigned a recall classification, and no public press release had been issued; patients should contact their pharmacist or healthcare provider if they believe they have a recalled bottle and should not stop taking prescribed medication without medical advice.
Topics:businessnation-and-world#blood-pressure#chlorthalidone#dissolution-failure#fda#nation-and-world#recall
- Blood pressure medication recalled nationwide over manufacturing issue KOMO
- Blood pressure medication recalled for potential ineffectiveness KOLD
- The FDA Issued a Recall on Blood Pressure Medication Nationwide EatingWell
- More than 11K bottles of blood pressure drug recalled Cardiovascular Business
- Hypertension Drug Recall; Hantavirus Quarantine Ends; Bending Over and Miscarriage MedPage Today
Want the full story? Read the original reporting
Read on KOMO